Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced multimillion-dollar buyouts were GSK, Sanofi, ...

France’s biotech sector continues to evolve, blending a strong academic foundation with a growing number of startups tackling diverse disease areas. While funding remains a significant hurdle, ...